Home Page Twitter Facebook Linked-In YouTube Home Page Join List-Serve Privacy Policy ADAP Advocacy Association

About ADAPs About Us Contact Us Events Publications Media Clips Press Room Support

About giving more than just a handfull of hope...aaa+


The ADAP Advocacy Association (aaa+®) mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. aaa+® works with advocates, community, health care, government, patients, pharmaceutical companies and other stakeholders to assure that access to services recognize and afford persons living with HIV/AIDS to enjoy a healthy life.

aaa+® is the only national grassroots organization focused exclusively on ADAPs and ensuring that there are adequate resources nationwide to eliminate or prevent waiting lists for services. Our purpose is to better engage people living with HIV/AIDS by providing a platform whereby they can offer their personal experiences, challenges, knowledge, insight and solutions to solving this perpetual problem.

Breaking News

ADAP Advocacy Association Releases 2014 Annual Report:

"Affordable Care Act implementation has not slowed down client enrollment in ADAPs nationwide"

WASHINGTON, D.C. (July 28, 2015) – The ADAP Advocacy Association, also known as aaa+®, today released it 2014 Annual Report. Last year, relatively small waiting lists returned under the AIDS Drug Assistance Programs (ADAPs), as client enrollment has continued to expand despite implementation of the Affordable Care Act (ACA), or Obamacare. [PDF | DOC]


It’s All About The Money: How Mandatory Mail Order Pharmacy Puts The Lives of People Living With HIV and Hepatitis C At Risk
By: Michelle J. Sherman, RPh, FASCP, AAHIVP, MichRx Pharmacist Consulting Services, Inc.

Over the past couple of years health insurance companies have added HIV antiretroviral medications to their “Specialty Drug Lists.” This results in the drugs being placed on the highest copay tiers with the highest copay structure. In many cases, it is unaffordable for people living with HIV/AIDS. In addition, health insurers have forced clients to utilize mail order “Specialty Pharmacies” picked by the health insurance plan.

What is Specialty Drug?

In defining specialty drugs there are two main factors: cost and complexity. Using a cost-based approach, CMS [Centers for Medicare & Medicaid Services] categorizes a specialty drug as one with a minimum monthly cost of $600 with respect to the Medicare Part D drug benefit. Other organizations utilize a higher cost threshold for specialty classification that may be as much as double that of CMS. Complexity can encompass a number of factors and affect various groups, including patients, payers, manufacturers, and the pharmacy itself .

CLICK HERE to read more.

ADAP Update

ADAPs with Waiting Lists
(35 individuals in 1 state(s) on the ADAP Waiting List as of July 28, 2014)
Source: The ADAP Watch, National Alliance of State & Territorial AIDS Directors (NASTAD).

  • Eleven ADAPs have had cost-containment measures in place since April 1, 2013 (reported as of July 15, 2014).
  • No ADAPs currently anticipate additional cost-containment measures prior to March 31, 2015.

» Go to the ADAP Watch

Support Our Scholarship Fund

ADAP Directory

Home · Join List-Serve · About ADAPs · About Us · Blog · Events · Publications
Media Clips · Press Room · Support · Privacy · Contact Us